Astera Labs’ (ALAB) “Hold (C-)” Rating Reiterated at Weiss Ratings

Weiss Ratings restated their hold (c-) rating on shares of Astera Labs (NASDAQ:ALAB) in a research report released on Friday,Weiss Ratings reports.

Other equities research analysts have also recently issued research reports about the stock. Bank of America began coverage on shares of Astera Labs in a research report on Friday, October 3rd. They issued a “neutral” rating and a $230.00 price target for the company. Morgan Stanley upped their target price on Astera Labs from $155.00 to $200.00 and gave the stock an “overweight” rating in a report on Friday, August 29th. Needham & Company LLC lifted their price target on Astera Labs from $100.00 to $170.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. TD Cowen initiated coverage on Astera Labs in a research report on Wednesday, October 1st. They issued a “hold” rating and a $200.00 price target for the company. Finally, Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price objective on the stock. in a research report on Tuesday, July 22nd. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $162.06.

Astera Labs Trading Up 0.8%

Shares of ALAB stock opened at $164.97 on Friday. Astera Labs has a twelve month low of $47.13 and a twelve month high of $262.90. The stock has a fifty day simple moving average of $196.79 and a two-hundred day simple moving average of $132.42. The stock has a market capitalization of $27.42 billion, a price-to-earnings ratio of 294.59, a P/E/G ratio of 4.11 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm had revenue of $191.93 million for the quarter, compared to analyst estimates of $172.46 million. During the same quarter last year, the firm posted $0.13 earnings per share. The business’s revenue for the quarter was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Research analysts predict that Astera Labs will post 0.34 EPS for the current fiscal year.

Insider Activity at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 152,517 shares of the firm’s stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.33, for a total value of $25,978,220.61. Following the completion of the sale, the chief executive officer owned 450,001 shares of the company’s stock, valued at approximately $76,648,670.33. This trade represents a 25.31% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Sanjay Gajendra sold 280,000 shares of the business’s stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.02, for a total value of $47,605,600.00. Following the sale, the chief operating officer owned 5,525,545 shares in the company, valued at $939,453,160.90. The trade was a 4.82% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,092,997 shares of company stock worth $192,231,120 over the last ninety days. Corporate insiders own 12.50% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. raised its stake in Astera Labs by 29.6% in the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock worth $1,089,491,000 after acquiring an additional 2,751,747 shares during the last quarter. Alliancebernstein L.P. raised its stake in shares of Astera Labs by 114.2% in the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock worth $501,289,000 after purchasing an additional 4,478,741 shares during the last quarter. Atreides Management LP boosted its position in Astera Labs by 153.3% in the first quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock valued at $277,601,000 after buying an additional 2,815,614 shares during the last quarter. State Street Corp boosted its position in Astera Labs by 39.3% in the second quarter. State Street Corp now owns 2,143,459 shares of the company’s stock valued at $193,812,000 after buying an additional 604,363 shares during the last quarter. Finally, Fred Alger Management LLC increased its holdings in Astera Labs by 13.0% in the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock worth $93,087,000 after buying an additional 179,638 shares during the period. 60.47% of the stock is currently owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.